- Home
- ARLP vs VRDN Comparison
ARLP vs VRDN Comparison
Compare ARLP & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARLP | VRDN |
|---|---|---|
| Founded | 1971 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ARLP | VRDN |
|---|---|---|
| Price | $27.03 | $30.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $29.50 | ★ $41.17 |
| AVG Volume (30 Days) | 456.4K | ★ 1.2M |
| Earning Date | 05-04-2026 | 05-25-2026 |
| Dividend Yield | ★ 8.90% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,002,857,000.00 | $5,706,000.00 |
| Revenue This Year | $3.84 | $13.90 |
| Revenue Next Year | $3.73 | $284.55 |
| P/E Ratio | $10.68 | ★ N/A |
| Revenue Growth | ★ 11.50 | N/A |
| 52 Week Low | $22.41 | $9.90 |
| 52 Week High | $28.14 | $34.29 |
Technical Indicators
Market Signals| Indicator | ARLP | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 68.53 | 52.88 |
| Support Level | $25.62 | $21.50 |
| Resistance Level | $27.73 | $33.71 |
| Average True Range (ATR) | 0.67 | 1.60 |
| MACD | 0.08 | 0.26 |
| Stochastic Oscillator | 79.40 | 92.69 |
Price Performance
Historical ComparisonAbout ARLP Alliance Resource Partners L.P.
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).